Financial toxicity

Questions discussed in this category

What are your top takeaways from SGO 2022?

10 Answers available

What are your top takeaways from SGO 2023?

7 Answers available

Papers discussed in this category

N Engl J Med, 2021 Sep 18

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.

N Engl J Med, 2022 Jan 19

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.

N Engl J Med, 2023 Mar 27

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

N Engl J Med, 2023 Mar 27

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

Related Topics